Although we hope to improve tumor-associated edema and secondary edema associated with chemoradiation therapy, which is usually treated with high dose of steroids, we expect that antagonizing AQP4 in GMB will result in secondary brain edema and that any approach targeting the activity of AQP4 in GBM may require continuous steroid treatment. The gene discussed is AQP4; the disease is glioblastoma.